Redinbo M R, Stewart L, Kuhn P, Champoux J J, Hol W G
Biomolecular Structure Center and Department of Biological Structure, Box 357742, School of Medicine, University of Washington, Seattle, WA 98195, USA.
Science. 1998 Mar 6;279(5356):1504-13. doi: 10.1126/science.279.5356.1504.
Topoisomerases I promote the relaxation of DNA superhelical tension by introducing a transient single-stranded break in duplex DNA and are vital for the processes of replication, transcription, and recombination. The crystal structures at 2.1 and 2.5 angstrom resolution of reconstituted human topoisomerase I comprising the core and carboxyl-terminal domains in covalent and noncovalent complexes with 22-base pair DNA duplexes reveal an enzyme that "clamps" around essentially B-form DNA. The core domain and the first eight residues of the carboxyl-terminal domain of the enzyme, including the active-site nucleophile tyrosine-723, share significant structural similarity with the bacteriophage family of DNA integrases. A binding mode for the anticancer drug camptothecin is proposed on the basis of chemical and biochemical information combined with these three-dimensional structures of topoisomerase I-DNA complexes.
拓扑异构酶I通过在双链DNA中引入瞬时单链断裂来促进DNA超螺旋张力的松弛,对于复制、转录和重组过程至关重要。由核心结构域和羧基末端结构域组成的重组人拓扑异构酶I与22碱基对DNA双链体形成的共价和非共价复合物,在2.1埃和2.5埃分辨率下的晶体结构显示,该酶“夹住”了基本为B型的DNA。该酶的核心结构域和羧基末端结构域的前八个残基,包括活性位点亲核试剂酪氨酸-723,与噬菌体DNA整合酶家族具有显著的结构相似性。基于化学和生化信息以及拓扑异构酶I-DNA复合物的这些三维结构,提出了抗癌药物喜树碱的结合模式。